American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Venetoclax-based therapy versus intensive chemotherapy followed by allogeneic-stem cell transplantation for high-risk elderly acute myeloid leukemia
    Meeting Abstract

    Iat, A.; Bewersdorf, J. P.; Gilhodes, J.; Liu, Y.; Shallis, R. M.; Boussi, L.; Zucenka, A.; Bystrom, R. P.; Deangelo, D. J.; Berton, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Derivation and external validation of a venous thromboembolism risk prediction model in patients with acute lymphoblastic leukemia receiving asparaginase therapy
    Meeting Abstract

    Anderson, D. R.; Gangaraju, R.; Sedhom, W.; Hamulyak, E. N.; Wang, T. F.; O'Dwyer, K. M.; Carney, B. J.; Muthiah, C.; Liedtke, M.; Badar, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Predictive modeling of clonal hematopoiesis across diverse cohorts
    Meeting Abstract

    Batchi-Bouyou, A. L.; Tran, D.; Raddatz, M.; Gao, T.; Vlasschaert, C.; Sharber, B.; Liu, J.; Petrone, G.; Chan, I. C. C.; Beeler, J. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Venous thromboembolism incidence in patients with cancer and factor XI deficiency
    Meeting Abstract

    Chrysafi, P.; Derkach, A.; Zwicker, J. I.; Leader, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Anticoagulation and major bleeding or recurrent thrombosis in patients with isolated cancer-associated splanchnic vein thrombosis: A multi-center cohort study
    Meeting Abstract

    Andersen, M. Jr; Shang, H.; Turizo, Mjjf; Jiang, J. Y.; Guffey, D.; Berry, J.; Zwicker, J. I.; Patell, R.; Li, A.
    Blood (2024)

    Fulltext@MSK | Save
  • Cevostamab in patients with heavily pretreated relapsed/refractory multiple myeloma (RRMM): Updated results from an ongoing phase i study demonstrate clinically meaningful activity and manageable safety and inform the doses and regimen for combination studies
    Meeting Abstract

    Richter, J.; Thomas, S. K.; Krishnan, A. Y.; Laubach, J. P.; Cohen, A. D.; Trudel, S.; Costa, L. J.; Bahlis, N. J.; Forsberg, P. A.; Kaedbey, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Imaging predictors of intracerebral hemorrhage in patients with brain tumors treated with anticoagulation
    Meeting Abstract

    Barnea, R.; Naftali, J.; Hamulyak, E. N.; Peseski, A. M.; Wang, T. F.; Kreuziger, L. B.; Iyengar, V.; Carney, B. J.; OĢˆzdemir, B.; Serrano, R. D. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Superiority of post-transplant cyclophosphamide-based graft versus host disease (GvHD) prophylaxis in patients 70 years and older: A BMT CTN 1703 post-hoc analysis
    Meeting Abstract

    Abedin, S.; Lian, Q. H.; Martens, M. J.; Malki, M. M. A.; Elmariah, H.; Gooptu, M.; Larkin, K. T.; Shaffer, B. C.; Loren, A. W.; Solh, M. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Myofibroblast to T-zone reticular cell ratio identifies unicentric Castleman disease lymph nodes
    Meeting Abstract

    Brandstadter, J.; Lutge, M.; Lim, M. S.; Bagg, A.; Miller, I. D.; Gonzalez, M.; Austin, B.; Priore, S. F.; Ludewig, B.; Fajgenbaum, D. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD)-adapted duration of front-line venetoclax and obinutuzumab treatment for fit patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Mato, A. R.; Zelenetz, A. D.; Park, J. H.; Geyer, M. B.; Derkach, A.; Nemirovsky, D.; Islam, P.; Falchi, L.; Palomba, M. L.; more...
    Blood (2024)

    Fulltext@MSK | Save